🟢 Ocugen is trading 5.7% up today with prior-session Q3 results potentially supporting gains

Ocugen is trading at MXN 16.91, up 5.69%, with its prior-session Q3 results potentially supporting the gain.

• Its November 4 report showed $1.95 million in revenue, above the $1.08 million consensus estimate, and a reported loss of $0.01 per share.
• The update highlighted completed Phase III enrollment for OCU400 and cash expected to fund operations into 2028.
• No separate November 5 company announcement was identified.